Brookdale (BKD) Q3 earnings report preview: what to look for

Senior living provider Brookdale Senior Living (NYSE:BKD) will be reporting results this Friday before market open. Here’s what to look for.

Brookdale missed analysts’ revenue expectations last quarter, reporting revenues of $718.6 million, down 11.6% year on year. It was a mixed quarter for the company, with a beat of analysts’ EPS estimates but full-year EBITDA guidance meeting analysts’ expectations.

Is Brookdale a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.

This quarter, the market is expecting Brookdale’s revenue to decline 12% year on year, a reversal from the 3.7% increase it recorded in the same quarter last year.

Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business will stay the course heading into earnings.

Looking at Brookdale’s peers in the senior health, home health & hospice segment, some have already reported their Q3 results, giving us a hint as to what we can expect. BrightSpring Health Services delivered year-on-year revenue growth of 26.4%, beating analysts’ expectations by 8.9%, and AdaptHealth reported a revenue decline of 9.1%, topping estimates by 2.7%. BrightSpring Health Services traded up 10% following the results while AdaptHealth was also up 23.9%.

Read our full analysis of BrightSpring Health Services’s results here and AdaptHealth’s results here.

There has been positive sentiment among investors in the senior health, home health & hospice segment, with share prices up 9.1% on average over the last month. Brookdale is up 2.7% during the same time and is heading into earnings with an average analyst price target of $19.08 (compared to the current share price of $11.19).

WHILE YOU’RE HERE: The Next Palantir? One satellite company captures images of every point on Earth. Every single day. The Pentagon wants it. Hedge funds are using it to beat earnings. You’ve probably never heard of it.

This is what the early days of Palantir looked like before it became a giant. Same playbook. Different technology. If you missed Palantir, you need to see this. Claim The Stock Ticker for Free HERE.

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.